Page 22 - Pharmaceutical Firms

Granules forges strategic partnership with Greenko ZeroC for Kakinada plant

Under the collaboration, Greenko ZeroC will be supplying carbon free energy and enable green hydrogen along with its various chemical derivatives

Govt inquires pharma firms' stock, adequacy of Covid management drugs

Union Health Minister Mansukh Mandaviya on Thursday asked pharma companies to ensure adequate stocks and availability of all drugs, including those for Covid management, in the supply chain up to the retail level amid rise in coronavirus cases in some countries. He reviewed the status, adequacy of COVID-19 management drugs and production capacities with representatives of pharma companies through a virtual conference here so that India is equipped to effectively handle any situation. This review meeting was taken in view of the spike in COVID-19 cases in some countries including China, an official statement said. Through a presentation, the minister was briefed regarding the evolving global scenario. Mandaviya appreciated the pharma companies for their invaluable contribution during the pandemic in the country, the statement said. "India's pharmaceutical industry is robust, resilient and responsive. It is due to their strength that we could not only meet our down demand during the

WHO stands by action of issuing alert against Maiden Pharma cough syrup

Asserts that testing done in labs in Ghana and Switzerland confirmed excess levels of contaminated syrups that are "dangerous and should not be in any medicine, ever"

Maiden Pharma's cough syrups are safe, WHO jumped the gun: DCGI

'Irreparable damage' to Indian pharma's global image, drug regulator writes to WHO

Fosun's sale of Gland Pharma to become India's biggest pharma deal: Report

With the acquisition, Gland pharma may also get access to global companies like AstraZeneca, Sanofi, Mylan, and Organon

Drug regulators, pharma firms step up action on fake and substandard drugs

Detection of spurious and substandard drugs was up by 47% from 2020 to 2021, according to an ASPA Report

Pharma logs 17% growth in Nov; anti-infective therapy drives market demand

Key antibiotic brands like Augmentin (GSK) and Clavam (Alkem) clocked 25 per cent and 29 percent growth, respectively, in November, the data showed

Innovator drugs maintain market hold even after patent expiry, shows data

Merck's anti-diabetic molecule sitagliptin retains 81% market share in value terms

Viatris deal gives Biocon Biologics entry in 100 countries: Shreehas Tambe

In a Q&A, the recently named MD & CEO of Biocon Biologics dwells on the scope for an IPO or stake sale to PE investors to retire the debt taken to fund the acquisition

Price war begins for Novartis cardiac drug as JB Pharma cuts rate by 50%

Novartis' blockbuster drug is set to lose patent in Jan; JB Pharma, one of the four marketers in India of generi versions, has slashed the price of its brand Azmarda to Rs 39.6 a tablet

Lessons from Covid: Pharma firms turn attention to adult vaccination

Vaccine companies have warmed up to the idea of adult vaccines for other diseases such as pneumonia, flu and shingles as well

Pharma, consumer durables sectors likely to feel China curb heat

Industry players say lockdown could have an impact on the supply of components used in consumer durables

Fosun plans to sell of India's $3.8 billion drug maker Gland Pharma

Fosun Pharma, a listed arm of Chinese conglomerate Fosun International Ltd., has been working with an adviser as it informally gauges interest in its controlling stake in Gland, the people said

Orchid Pharma antibiotic product for treating UTI coming to India: MD

Company says it's returning to profit after takeover by Dhanuka Laboratories under insolvency resolution

SK Bioscience suspends production of Covid-19 vaccine 'Sky Covione'

It previously obtained item approval on June 29 and supplied vaccines on September under a pre-purchase contract with the government, but suspended production due to low market demand

World's most expensive drug approved to treat Hemophilia at $3.5 mn a dose

CSL Behring's Hemgenix, administered just once, cut the number of bleeding events expected over the course of a year by 54%, a key study of the therapy found

Top 300 drug brands to now have QR codes on label for ensuring authenticity

Govt finalises the draft notification issued in June

A viral message in the Moderna story

In The Messenger, The Wall Street Journal reporter Peter Loftus charts the journey of Moderna from being a languishing biotech start-up to one of the biggest financial beneficiaries of the pandemic

CM Basavaraj Bommai emphasises cooperation with US in pharma sector

Chief Minister Basavaraj Bommai emphasized the importance of setting up a working group between US officials and the Karnataka government for increasing pharma-related R & D as well as drug production in the state.He was interacting with a delegation led by Rahul Gupta, Director of the White House Office of National Drug Control Policy at his Home Office Krishna. Rahul Gupta explained in detail the measures President Joe Biden's Office took to increase cooperation between India and the USA in Drug Policy Formulation and Drug production and in the field of Narcotic Drugs Control.He agreed to initiate necessary dialogue in this direction and sought the indulgence of CM Bommai to facilitate more investments by US companies in the Pharma sector in Karnataka.CM Bommai stated that Karnataka has already become a hub of drug research and welcomed more investments by US companies in drug and vaccine production for the world.The US delegation included Harinder S. Panesar, President of the ..

Trying to lock in vendors who don't want to buy from China: Biocon CEO & MD

Siddharth Mittal, CEO & MD, Biocon, elaborates on his plans to grow this business further